logo

For the Inventor, By the Inventor

Vienna, Austria

Intercell Ag


USPTO Granted Patents = 36

% Expired Patents = 80.6



Trademarks = 1

Forward Citations = 267

Loading Chart...
Loading Chart...

74 inventors (with patents filed for the assignee):

goldMedal Andreas Meinke (23 out of 46 patents)

silverMedal Eszter Nagy (21 out of 42 patents)

bronzeMedal Markus Hanner (9 out of 19 patents)

4.  Michael Buschle (8 out of 12 patents)

5.  Frank Mattner (7 out of 22 patents)

6.  Wolfgang Zauner (6 out of 10 patents)

7.  Alexander Von Gabain (6 out of 10 patents)

8.  Dieter Gelbmann (5 out of 6 patents)

9.  Walter G Schmidt (5 out of 23 patents)

10.  Karen Lingnau (4 out of 12 patents)

11.  Christoph Klade (4 out of 7 patents)

12.  Ulrike Stierschneider (4 out of 6 patents)

13.  Oresta Vytvytska (4 out of 5 patents)

14.  Urban Lundberg (3 out of 21 patents)

15.  Markus Horky (3 out of 4 patents)


Core Competencies:
Attenuated Live Vaccine
Influenza Antibodies
S. Epidermidis Antigens
Vaccine Composition
Antigen Production
Pharmaceutical Composition
Immunostimulatory Molecules
Hepatitis C Peptides
Vaccine Formulations
Antigenic Composition
Polymeric Compounds
Immune Responses

36 patents:

1. 8486419 - Attenuated live vaccine (2013-07-16),
2. 8460670 - Fully human influenza M2 specific antibodies (2013-06-11),
3. 8449892 - [object Object] (2013-05-28),
4. 8445001 - [object Object] (2013-05-21),
5. 8431128 - [object Object] (2013-04-30),
6. 8372411 - [object Object] (2013-02-12),
7. 8372410 - S. epidermidis antigens (2013-02-12),
8. 8361476 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2013-01-29),
9. 8349336 - [object Object] (2013-01-08),
10. 8343510 - [object Object] (2013-01-01),
11. 8323660 - Method for identification, isolation and production of antigens to a specific pathogen (2012-12-04),
12. 8318908 - Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof (2012-11-27),
13. 8303961 - [object Object] (2012-11-06),
14. 8277815 - Pharmaceutical composition comprising an antigen (2012-10-02),
15. 8241643 - [object Object] (2012-08-14),
Intercell AG, based in Vienna, Austria, is a biotechnology company focused on the development of innovative vaccines and immune therapies. The organization specializes in harnessing the immune system to combat infectious diseases and cancer, leveraging advanced research in immunology and vaccine technology. Intercell's commitment to addressing unmet medical needs positions it as a key player in the biopharmaceutical sector, contributing to global health advancements through its cutting-edge solutions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

36 Patents

#22 in Vienna

#101 in Austria

#18,697 in the World

Vienna, AT
Vienna, Austria

Intercell Ag

Forward Citations = 267

74 inventors:

goldMedal Andreas Meinke (23 out of 46 patents)

silverMedal Eszter Nagy (21 out of 42 patents)

bronzeMedal Markus Hanner (9 out of 19 patents)

4.  Michael Buschle (8 out of 12 patents)

5.  Frank Mattner (7 out of 22 patents)

Please report any incorrect information to [email protected]
Loading…